Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1

Conditions

Hematologic Neoplasms 2COVID-19 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Chronic Disease 1

Interventions

cilgavimab and tixagevimab drug combination 2Standard of Care 2Specimen Handling 2Practice Guidelines as Topic 2CVnCoV COVID-19 vaccine 2COH04S1 COVID-19 vaccine 2BNT162 Vaccine 2sotrovimab 1ogalvibart 1crexavibart 1bemcentinib 1Therapeutics 1Surveys and Questionnaires 1Hydroxychloroquine 1HuMax-IL8 1Data Collection 1COVID-19 Vaccines 1Blood Specimen Collection 1Azithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
COVID-19 × BNT162 Vaccine × Other hematologic neoplasm × Clear all
NCT04951323 2022-05-18

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

University of Liege

Phase 3 Unknown
50 enrolled
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT04743388 2022-04-11

Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System

National and Kapodistrian University of Athens

Unknown
600 enrolled
Other hematologic neoplasm

COVID-19, Chronic Disease, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡